Related Experiment Video
Updated: Jul 8, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
The treatment of the first seizure: the benefits
1University of Liverpool, Walton Centre, Liverpool, United Kingdom. D.W.Chadwick@liverpool.ac.uk
Abstract:
The benefits of antiepileptic drug treatment are among the best quantified of any area of epilepsy management, because of the number and quality of randomized controlled trials, systematic reviews, and meta-analyses that address these issues. It is evident that there are groups of readily identified patients at higher risk of seizure recurrence for whom the benefits of early drug treatment in preventing short-term seizure recurrence may be attractive for individual patients, although for the majority of patients at lower risk, benefit is minimal. It is now possible to exclude any modification of the long-term prognosis for patients arising from early treatment.
More Related Videos
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction
Electroconvulsive Therapy
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

